Cancer-related Fatigue and Symptom Clusters - Effects of Virtual, Imagined and Real-life Nature-based Therapy in Cancer Survivors
NCT ID: NCT06931132
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
172 participants
INTERVENTIONAL
2025-06-05
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-Media Imagery Program for Breast Cancer Patients (Phase II)
NCT01034215
Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response
NCT01919853
Home-Based Programs for Improving Sleep in Cancer Survivors
NCT00993928
Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH
NCT02759549
Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
NCT02954809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real-life FOREST bathing
Real-life forest bathing
Participants will experience the elements (olfactory, acoustic and haptic) of forest bathing for 30 minutes (sitting) in a forested area. The forests have been previously selected near Stuttgart and Würzburg and are comparable to each other.
Simulated FOREST bathing (Virtual Reality).
Simulated FOREST bathing (Virtual Reality)
Using virtual reality goggles, a FOREST bathing experience will be simulated. The simulation will have elements of the classic FOREST bathing (olfatory, acoustic and haptic) and will last 30 minutes.
Imaging FOREST bathing.
Imaging FOREST bathing
A therapist will lead an imaginative exercise in which participants will imagine a FOREST bathing. The imaginative exercise will include elements of the classic FOREST bathing (olfactory, acoustic and haptic) and will last 30 minutes.
Wait-list group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real-life forest bathing
Participants will experience the elements (olfactory, acoustic and haptic) of forest bathing for 30 minutes (sitting) in a forested area. The forests have been previously selected near Stuttgart and Würzburg and are comparable to each other.
Simulated FOREST bathing (Virtual Reality)
Using virtual reality goggles, a FOREST bathing experience will be simulated. The simulation will have elements of the classic FOREST bathing (olfatory, acoustic and haptic) and will last 30 minutes.
Imaging FOREST bathing
A therapist will lead an imaginative exercise in which participants will imagine a FOREST bathing. The imaginative exercise will include elements of the classic FOREST bathing (olfactory, acoustic and haptic) and will last 30 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjective Impairment due to Cancer-Related Fatigue (CrF) . NCCN-recommended questions are used for screening ("How exhausted do you feel on a scale of 0 to 10?" and "How impaired do you feel by this fatigue on a scale of 0 to 10?" (threshold \>4 on either scale).
* At the time of study inclusion, it must be expected that no further antitumor therapy measures will be started within the next 6 months.
* Patients must be able to refrain from smoking up to 15 minutes before the intervention (smoking within 15 minutes before therapy impairs the participant's ability to perceive the aroma of the phytoncides).
* Written and valid informed consent from the patient.
Exclusion Criteria
* Asthma (inhaled phytoncides may cause airway irritation, exacerbation of asthma, or bronchoconstriction).
* Known allergy to pine or citrus fragrance.
* Anosmie.
* Medical history of seasickness (virtual reality can cause nausea/vomiting with no improvement after 5-10 minutes).
* History of seizures (virtual reality may increase susceptibility to seizures due to the changing light in the forest video).
* Visual and hearing impairments that are not corrected by visual or hearing aids.
* Unwillingness to store and share personal medical data as part of the protocol.
* Participation in another clinical trial focusing on behavioural or complementary medicine interventions.
* Missing or incomplete consent form.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuerzburg University Hospital
OTHER
University Hospital Tuebingen
OTHER
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcela Winkler, MD
Head of Integrative Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Loeffler, Dr.
Role: PRINCIPAL_INVESTIGATOR
Würzburg University. Würzburg, Bayern, Germany, 97080
Marcela Winkler, Dr.
Role: PRINCIPAL_INVESTIGATOR
Robert-Bosch-Krankenhaus, Stuttgart, Baden Würtemberg, Germany, 70341
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr med. Marcela Winkler
Stuttgart, Baden-Wurttemberg, Germany
PD Dr. Claudia Löffler
Würzburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S00855-NIM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.